Therefore, although ABCG1 methylation alone may not serve as an adequate screening marker, the combination of additional biomarkers along with CHD-related environmental factors might be helpful for the risk evaluation and early detection of CHD in future. Here, ABCG1 is linked to coronary artery disorder.